Modulators of metabolism and the treatment of disorders related thereto

Details for Australian Patent Application No. 2006292620 (hide)

Owner Arena Pharmaceuticals, Inc.

Inventors Lehmann, Juerg; Jones, Robert M.

Agent FB Rice

Pub. Number AU-A-2006292620

PCT Pub. Number WO2007/035355

Priority 60/718,015 16.09.05 US

Filing date 14 September 2006

Wipo publication date 29 March 2007

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 5/50 (2006.01) Drugs for disorders of the endocrine system

Event Publications

6 March 2008 PCT application entered the National Phase

  PCT publication WO2007/035355 Priority application(s): WO2007/035355

9 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  Application withdrawn under section 141(1). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006292637-Polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-di hydro3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]m ethyl]-benzonitrile and methods of use therefor

2006292617-Connecting to different network types through a common user interface